468 related articles for article (PubMed ID: 27128602)
1. Lymph node ratio and surgical quality are strong prognostic factors of rectal cancer: results from a single referral centre.
Leonard D; Remue C; Abbes Orabi N; van Maanen A; Danse E; Dragean A; Debetancourt D; Humblet Y; Jouret-Mourin A; Maddalena F; Medina Benites A; Scalliet P; Sempoux C; Van den Eynde M; De Schoutheete JC; Kartheuser A
Colorectal Dis; 2016 Jun; 18(6):O175-84. PubMed ID: 27128602
[TBL] [Abstract][Full Text] [Related]
2. Prognostic Value of Lymph Node Ratio in Locally Advanced Rectal Cancer Patients After Preoperative Chemoradiotherapy Followed by Total Mesorectal Excision.
Zuo ZG; Zhang XF; Wang H; Liu QZ; Ye XZ; Xu C; Wu XB; Cai JH; Zhou ZH; Li JL; Song HY; Luo ZQ; Li P; Ni SC; Jiang L
Medicine (Baltimore); 2016 Mar; 95(9):e2988. PubMed ID: 26945418
[TBL] [Abstract][Full Text] [Related]
3. Is it time to rethink the rule of total mesorectal excision? A prospective radiological and pathological study in 49 consecutive patients with mid-rectal cancer.
Guedj N; Zappa M; Maggiori L; Bertin C; Hennequin C; Panis Y
Colorectal Dis; 2016 Sep; 18(9):O314-21. PubMed ID: 27381492
[TBL] [Abstract][Full Text] [Related]
4. Lymph node ratio is an independent prognostic factor in node positive rectal cancer patients treated with preoperative chemoradiotherapy followed by curative resection.
Zeng WG; Zhou ZX; Wang Z; Liang JW; Hou HR; Zhou HT; Zhang XM; Hu JJ
Asian Pac J Cancer Prev; 2014; 15(13):5365-9. PubMed ID: 25041003
[TBL] [Abstract][Full Text] [Related]
5. lymph node ratio as a prognostic factor in patients with stage III rectal cancer treated with total mesorectal excision followed by chemoradiotherapy.
Kim YS; Kim JH; Yoon SM; Choi EK; Ahn SD; Lee SW; Kim JC; Yu CS; Kim HC; Kim TW; Chang HM
Int J Radiat Oncol Biol Phys; 2009 Jul; 74(3):796-802. PubMed ID: 19289261
[TBL] [Abstract][Full Text] [Related]
6. Impact of Lymph Node Ratio on Oncologic Outcomes in ypStage III Rectal Cancer Patients Treated with Neoadjuvant Chemoradiotherapy followed by Total Mesorectal Excision, and Postoperative Adjuvant Chemotherapy.
Koo T; Song C; Kim JS; Kim K; Chie EK; Kang SB; Lee KW; Kim JH; Jeong SY; Kim TY
PLoS One; 2015; 10(9):e0138728. PubMed ID: 26381522
[TBL] [Abstract][Full Text] [Related]
7. The importance of lymph node retrieval and lymph node ratio following preoperative chemoradiation of rectal cancer.
La Torre M; Mazzuca F; Ferri M; Mari FS; Botticelli A; Pilozzi E; Lorenzon L; Osti MF; Marchetti P; Enrici RM; Ziparo V
Colorectal Dis; 2013 Jul; 15(7):e382-8. PubMed ID: 23581854
[TBL] [Abstract][Full Text] [Related]
8. Neoadjuvant therapy does not affect lymph node ratio in rectal cancer.
Chang KH; Kelly NP; Duff GP; Condon ET; Waldron D; Coffey JC
Surgeon; 2016 Oct; 14(5):270-3. PubMed ID: 26148760
[TBL] [Abstract][Full Text] [Related]
9. [Prognostic value of lymph node ratio in survival of patients with stage III rectal cancer].
Zhu XW; Wu CS; Yuan SC
Zhonghua Zhong Liu Za Zhi; 2012 Jul; 34(7):506-9. PubMed ID: 22967468
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of metastatic lymph node regression grade after neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer.
Tominaga T; Akiyoshi T; Yamamoto N; Oba K; Nagasaki T; Yamaguchi T; Konishi T; Fukunaga Y; Ueno M
Surgery; 2019 Dec; 166(6):1061-1067. PubMed ID: 31345564
[TBL] [Abstract][Full Text] [Related]
11. The prognostic impact of neoadjuvant chemoradiotherapy on lymph node sampling in patients with locally advanced rectal cancer.
Li Destri G; Maugeri A; Ramistella A; La Greca G; Conti P; Trombatore G; Vecchio GM; Magro GG; Barchitta M; Agodi A
Updates Surg; 2020 Sep; 72(3):793-800. PubMed ID: 32632764
[TBL] [Abstract][Full Text] [Related]
12. Comparison of three classifications for lymph node evaluation in patients undergoing total mesorectal excision for rectal cancer.
Fritzmann J; Contin P; Reissfelder C; Büchler MW; Weitz J; Rahbari NN; Ulrich AB
Langenbecks Arch Surg; 2018 Jun; 403(4):451-462. PubMed ID: 29523953
[TBL] [Abstract][Full Text] [Related]
13. Lymph node ratio is an independent prognostic factor in patients with rectal cancer treated with preoperative chemoradiotherapy and curative resection.
Lee SD; Kim TH; Kim DY; Baek JY; Kim SY; Chang HJ; Park SC; Park JW; Oh JH; Jung KH
Eur J Surg Oncol; 2012 Jun; 38(6):478-83. PubMed ID: 22465588
[TBL] [Abstract][Full Text] [Related]
14. Impact of lymph node ratio and number on survival in patients with rectal adenocarcinoma after preoperative chemo radiation.
Bhatti ABH; Akbar A; Hafeez A; Syed AA; Khattak S; Jamshed A; Kazmi AS
Int J Surg; 2015 Jan; 13():65-70. PubMed ID: 25475873
[TBL] [Abstract][Full Text] [Related]
15. Quantitative lymph node evaluation as an independent marker of long-term prognosis in stage III rectal cancer.
Vather R; Sammour T; Kahokehr A; Connolly A; Hill A
ANZ J Surg; 2011 Dec; 81(12):883-8. PubMed ID: 22507414
[TBL] [Abstract][Full Text] [Related]
16. Ratio of metastatic lymph nodes is more important for rectal cancer patients treated with preoperative chemoradiotherapy.
Park IJ; Yu CS; Lim SB; Yoon YS; Kim CW; Kim TW; Kim JH; Kim JC
World J Gastroenterol; 2015 Mar; 21(11):3274-81. PubMed ID: 25805934
[TBL] [Abstract][Full Text] [Related]
17. Increased Lymph Node Yield Is Associated With Improved Survival in Rectal Cancer Irrespective of Neoadjuvant Treatment: Results From a National Cohort Study.
Lykke J; Jess P; Roikjaer O;
Dis Colon Rectum; 2015 Sep; 58(9):823-30. PubMed ID: 26252843
[TBL] [Abstract][Full Text] [Related]
18. Prognostic importance of lymph node count and ratio in rectal cancer after neoadjuvant chemoradiotherapy: Results from a cross-sectional study.
Detering R; Meyer VM; Borstlap WAA; Beets-Tan RGH; Marijnen CAM; Hompes R; Tanis PJ; van Westreenen HL;
J Surg Oncol; 2021 Sep; 124(3):367-377. PubMed ID: 33988882
[TBL] [Abstract][Full Text] [Related]
19. Log odds of positive lymph nodes is a superior prognostic indicator in stage III rectal cancer patients: A retrospective analysis of 17,632 patients in the SEER database.
Huang B; Chen C; Ni M; Mo S; Cai G; Cai S
Int J Surg; 2016 Aug; 32():24-30. PubMed ID: 27321382
[TBL] [Abstract][Full Text] [Related]
20. Scoring the quality of total mesorectal excision for the prediction of cancer-specific outcome.
Leonard D; Penninckx F; Laenen A; Kartheuser A;
Colorectal Dis; 2015 May; 17(5):O115-22. PubMed ID: 25714054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
